Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

V-IMMUNE® for Immune Thrombocytopenia: A Prospective Multicenter Study to Evaluate the Efficacy and Safety of Human Immunoglobulin in Adult and Pediatric Participants With Immune Thrombocytopenia. TIP Study

NCT06962631 is registered in ClinicalTrials.gov with On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. as lead sponsor.

NCT NCT06962631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
V-IMMUNE® for Immune Thrombocytopenia: A Prospective Multicenter Study to Evaluate the Efficacy and Safety of Human Immunoglobulin in Adult and Pediatric Participants With Immune Thrombocytopenia. TIP Study
Lead sponsor
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.
Phase
Phase 3
Overall status
Recruiting
Start date
July 18, 2025
Completion date
February 27, 2027
Enrollment
31 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia (itp)